Avanir Pharmaceuticals, Inc.
is a biopharmaceutical company focused on acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders.

Press Releases

Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study
Jun 30, 2015
Avanir Pharmaceuticals Announces Publication of Positive Phase IIIb Results from AVP-825 Head-to-Head COMPASS Study in the...
Jun 17, 2015
Avanir Pharmaceuticals Announces Presentation of Survey Evaluating the Prevalence of Pseudobulbar Affect (PBA) Symptoms in...
May 5, 2015
Divider